172 related articles for article (PubMed ID: 457017)
1. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
Arntz HR; Dreykluft HR; Leonhardt H
Fortschr Med; 1979 Jul; 97(27):1212-4. PubMed ID: 457017
[TBL] [Abstract][Full Text] [Related]
2. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
Mertz DP
MMW Munch Med Wochenschr; 1978 Oct; 120(42):1387-90. PubMed ID: 101792
[TBL] [Abstract][Full Text] [Related]
3. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
Fortschr Med; 1979 May; 97(17):835-6. PubMed ID: 437646
[No Abstract] [Full Text] [Related]
4. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
Matzkies F; Berg G
Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
[TBL] [Abstract][Full Text] [Related]
6. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
Mertz DP
Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness and tolerance of long-term uricosuric treatment].
Berg H
Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
[TBL] [Abstract][Full Text] [Related]
8. Benzbromarone therapy in hyperuricaemia; comparison with allopurinol and probenecid.
Schepers GW
J Int Med Res; 1981; 9(6):511-5. PubMed ID: 7033016
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
Hanvivadhanakul P; Akkasilpa S; Deesomchok U
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
[TBL] [Abstract][Full Text] [Related]
10. [Allomaron in hyperuricemia and gout].
Barsom S
ZFA (Stuttgart); 1979 Aug; 55(24):1336-40. PubMed ID: 539082
[No Abstract] [Full Text] [Related]
11. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
Mertz DP
Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
[No Abstract] [Full Text] [Related]
12. [Prevention of urinary calculi by means of a benzbromarone-citrate combination].
Bach D; Hesse A; Strenge A; Vahlensieck W
Fortschr Med; 1980 Nov; 98(44):1752-5. PubMed ID: 7461567
[TBL] [Abstract][Full Text] [Related]
13. [The correction of hyperuricemia in patients with different forms of nephrolithiasis using allopurinol and Allomaron].
Darenkov AF; Konstantinova OV; Ianenko EK
Urol Nefrol (Mosk); 1994; (5):35-7. PubMed ID: 7871619
[TBL] [Abstract][Full Text] [Related]
14. [Uric acid-lowering effect of a combination of benzbromarone and allopurinol--studies under standardized dietary conditions].
Löffler W; Gröbner W; Zöllner N
Arzneimittelforschung; 1983; 33(12):1687-91. PubMed ID: 6686776
[TBL] [Abstract][Full Text] [Related]
15. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
Mertz DP
Dtsch Med Wochenschr; 1976 Aug; 101(35):1288-92. PubMed ID: 782809
[No Abstract] [Full Text] [Related]
16. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
17. [The treatment of hyperuricemia after kidney transplantation].
Flury W; Ruch HR; Montandon A
Schweiz Med Wochenschr; 1977 Sep; 107(38):1339-41. PubMed ID: 335500
[TBL] [Abstract][Full Text] [Related]
18. [The effect of benzbromaron in gout patients with limited kidney function].
Kuzmits R; Bresnik W; Müller MM
Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
[TBL] [Abstract][Full Text] [Related]
19. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
[TBL] [Abstract][Full Text] [Related]
20. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
Matzkies F; Neuwirth R; Berg G
Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
